{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:01Z","timestamp":1786119661275,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/mph.0b013e3181e90017","type":"journal-article","created":{"date-parts":[[2010,8,25]],"date-time":"2010-08-25T03:23:20Z","timestamp":1282706600000},"page":"e279-e284","source":"Crossref","is-referenced-by-count":5,"title":["Treatment of Pediatric Burkitt Lymphoma in Turkey"],"prefix":"10.1097","volume":"32","author":[{"given":"Tiraje T\u00fclin","family":"Celkan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Bari\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alp","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilmi","family":"Apak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer","family":"Do\u011fru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Karaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin","family":"Canbolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"Ozdil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal","family":"Aki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Adaletli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebuh","family":"Kurugoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Hallac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inci","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210227","first-page":"296","article-title":"Diagnosis and treatment of childhood non-Hodgkin lymphoma.","volume":"285-","author":"Reiter","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R2-19-20210227","first-page":"978","article-title":"Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria\u2014therapy results between 1986 and 2000","volume":"114","author":"Attarbaschi","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"R3-19-20210227","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1200\/JCO.1995.13.2.359","article-title":"Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage\u2014a report of the Berlin-Frankfurt-M\u00fcnster Group","volume":"13","author":"Reiter","year":"1995","journal-title":"J Clin Oncol"},{"key":"R4-19-20210227","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0305-7372(02)00108-1","article-title":"B large-cell lymphoma in children and adolescents","volume":"29","author":"Raetz","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"R5-19-20210227","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/pbc.20254","article-title":"The 2000 Burkitt lymphoma trial in Malawi","volume":"44","author":"Hesseling","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R6-19-20210227","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<333::AID-MPO2>3.0.CO;2-I","article-title":"Results of a BFM-based protocol for the treatment of childhood B-non-Hodgkin's lymphoma and B-acute lymphoblastic leukemia in Argentina","volume":"28","author":"Chantada","year":"1997","journal-title":"Med Pediatr Oncol"},{"issue":"2","key":"R7-19-20210227","first-page":"45","article-title":"Progress in the treatment of non-Hodgkin's lymphoma (NHL) in children. The report of Polish Pediatric Leukaemia\/lymphoma Study Group (PPLLSG)","volume":"61","author":"Wr\u00f3bel","year":"2004","journal-title":"Przegl Lek"},{"key":"R8-19-20210227","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/088800199277254","article-title":"Treatment of pediatric B-cell non-Hodgkin lymphoma at the Motol Hospital in Prague, Czech Republic: results based on the NHL BFM 90 protocols","volume":"16","author":"Kavan","year":"1999","journal-title":"Pediatr Hematol Oncol"},{"key":"R9-19-20210227","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/pbc.21144","article-title":"Treatment of pediatric non-Hodgkin Lymphoma in Hungary: 15 years experience with NHL-BFM 90 and 95 protocols","volume":"50","author":"M\u00fcller","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R10-19-20210227","first-page":"603","article-title":"The treatment results in children diagnosed with non-Hodgkin's lymphomas and acute B-cell lymphoblastic leukemias treated by the BFM protocols","volume":"49","author":"Vivanco Martinez","year":"1998","journal-title":"An Esp Pediatr"},{"key":"R11-19-20210227","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/mpo.10288","article-title":"Treatment of B-cell malignancies in children with a modified BFMNHL 90 protocol in Argentina","volume":"41","author":"Chantada","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"R12-19-20210227","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1365-2141.2003.04134.x","article-title":"Burkitt's and Burkitt like lymphoma in children and adolescents: a review of the Children's Cancer Group experience","volume":"120","author":"Cairo","year":"2003","journal-title":"Br J Haematol"},{"key":"R13-19-20210227","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/pbc.20116","article-title":"Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol","volume":"43","author":"Acquatella","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"R14-19-20210227","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/cncr.20382","article-title":"Long term results of the first Italian association of pediatric hematology-oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92)","volume":"101","author":"Pillon","year":"2004","journal-title":"Cancer"},{"key":"R15-19-20210227","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0609.2006.00735.x","article-title":"Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-M\u00fcnster-90 protocol","volume":"77","author":"Sun","year":"2006","journal-title":"Eur J Haematol"},{"key":"R16-19-20210227","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","article-title":"The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence","volume":"131","author":"Burkhardt","year":"2005","journal-title":"Br J Haematol"},{"key":"R17-19-20210227","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00277-003-0608-2","article-title":"Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma\/leukemia before and after introduction of prophylactic use of urate oxidase","volume":"82","author":"W\u00f6ssmann","year":"2003","journal-title":"Ann Hematol"},{"key":"R18-19-20210227","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","article-title":"The Soci\u00e9t\u00e9 Fran\u00e7aise d'Oncologie P\u00e9diatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"},{"key":"R19-19-20210227","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","article-title":"Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients","volume":"109","author":"Patte","year":"2007","journal-title":"Blood"},{"key":"R20-19-20210227","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","article-title":"The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95","volume":"105","author":"Woessmann","year":"2005","journal-title":"Blood"},{"key":"R21-19-20210227","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/01.mph.0000139772.98685.d2","article-title":"Intensive chemotherapy without radiotherapy gives more than 85% EFS for non-Hodgkin lymphoma without central nervous involvement: a 6-year population- based study from the nordic society of pediatric hematology-oncology","volume":"26","author":"Marky","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"R22-19-20210227","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/10428199409049650","article-title":"Chilhood B-cell non-Hodgkin's lymphoma in Israel","volume":"14","author":"Kaplinsky","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"R23-19-20210227","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.transci.2004.10.003","article-title":"Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa","volume":"32","author":"Wessels","year":"2005","journal-title":"Transfus Apher Sci"},{"key":"R25-19-20210227","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/08880010701450972","article-title":"Clinical characteristics and treatment results of pediatric B-cell non-Hodgkin's lymphomapatients in a single center","volume":"24","author":"Karadeniz","year":"2007","journal-title":"Pediatr Hematol Oncol"},{"key":"R26-19-20210227","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1081\/CNV-120002487","article-title":"Clinical characteristics and treatment results of LMB\/LMT regimen in chilhood with Non-Hodgkin's Lymphoma","volume":"20","author":"Kutluk","year":"2002","journal-title":"Cancer Invest"},{"key":"R27-19-20210227","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/10428199409049685","article-title":"Burkitt's lyphoma in Turkish children: clinical, viral (EBV) and molecular studies","volume":"14","author":"\u00c7avdar","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"R28-19-20210227","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated Kiel classification for lymphomas","volume":"1","author":"Stansfeld","year":"1988","journal-title":"Lancet"},{"key":"R29-19-20210227","first-page":"3294","article-title":"Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-M\u00fcnster Group Trial NHL-BFM 90","volume":"94","author":"Reiter","year":"1999","journal-title":"Blood"},{"key":"R30-19-20210227","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pbc.20121","article-title":"Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group","volume":"44","author":"Attarbaschi","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R31-19-20210227","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","article-title":"Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents","volume":"109","author":"Cairo","year":"2007","journal-title":"Blood"},{"key":"R32-19-20210227","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1200\/JCO.2007.11.0700","article-title":"Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report","volume":"25","author":"Salzburg","year":"2007","journal-title":"J Clin Oncol"},{"key":"R33-19-20210227","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1055\/s-2008-1043892","article-title":"Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin's lymphoma and B-ALL. Observations from the BFM-trials","volume":"210","author":"Seidemann","year":"1998","journal-title":"Klin Padiatr"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e3181e90017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:41:33Z","timestamp":1786041693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-201010000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3181e90017","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}